Relationship between anxiety, depression, and morbidity in adult asthma patients

Thorax

Volumn 56, Issue 4, 2001, Pages 266-271

  Rimington, L D ^a   Davies, D H ^b   Lowe, D ^a   Pearson, M G ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

Asthma; Depression; Morbidity

Indexed keywords

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ASTHMA; DEPRESSION; DISEASE SEVERITY; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SCORING SYSTEM; SYMPTOMATOLOGY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANXIETY DISORDERS; ASTHMA; BRONCHODILATOR AGENTS; COHORT STUDIES; DEPRESSIVE DISORDER; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; QUALITY OF LIFE; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; SUBURBAN HEALTH; URBAN HEALTH; VITAL CAPACITY;

EID: 0035059901     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.4.266     Document Type: Article

References (23)

1. The British guidelines on asthma management: 1995 review and position statement
2. The influence of psychological status on respiratory reporting
3. Anxiety and depression in relation to respiratory symptoms and asthma
4. Anxiety and depression amongst chronic severe asthmatics
5. Psychological factors and asthma
6. Measuring quality of life in asthma
7. The hospital anxiety and depression scale
8. Lung volumes and forced ventilatory flows. Report of Working Party on Standardisation of Lung Function Tests, European Community for Steel and Coal. Official Statement of the ERS
9. Metered dose inhaler adherence in a clinical trial
10. Compliance with inhaled therapy and morbidity from asthma
11. Actual over best function as an outcome measure for asthma
12. Determining minimal important change in a disease specific quality of life questionnaire
13. Accuracy of death certificates in bronchial asthma: Accuracy of certificate procedures during the confidential enquiry by The British Thoracic Society Research Committee
14. Asthma deaths in Mersey Region 1989-90
15. Psychosocial risk factors in near-fatal asthma and in asthma deaths
16. Psychological aspects of asthma and the consequent research implications
17. Hyperventilation: Its relation to symptom experience and to anxiety
18. Identification of underprivileged areas
19. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma
20. Quality of life measures in asthma: Do they matter to the GP?
21. Quality of life in asthma clinical trials: Comparison of salmeterol and salbutamol
22. Quality of life measurement in asthma